AGP Picks
View all

The Middle East Health Journal
Provided by AGP

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 12, 2026

Kyowa Kirin Introduces Family Outreach Initiative to Support Families Living with XLH
Aug. 12, 2026

Kyowa Kirin Introduces Family Outreach Initiative to Support Families Living with XLH

Indeterminate GlobeNewswire
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
Aug. 12, 2026

Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging

Indeterminate GlobeNewswire
Rising Costs, Legislation Impact Penn Highlands Healthcare Hospital Margins
Aug. 12, 2026

Rising Costs, Legislation Impact Penn Highlands Healthcare Hospital Margins

Indeterminate GlobeNewswire
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
Aug. 12, 2026

Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents

Indeterminate GlobeNewswire
LiveWorld Reports Second Quarter 2026 Financial Results
Aug. 12, 2026

LiveWorld Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
Aug. 12, 2026

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Indeterminate GlobeNewswire
Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation
Aug. 12, 2026

Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation

Indeterminate GlobeNewswire
AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article
Aug. 12, 2026

AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article

Indeterminate GlobeNewswire
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
Aug. 12, 2026

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

Indeterminate GlobeNewswire
Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot
Aug. 12, 2026

Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot

Indeterminate GlobeNewswire
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
Aug. 12, 2026

Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central

Indeterminate GlobeNewswire
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Aug. 12, 2026

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

Indeterminate GlobeNewswire
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
Aug. 12, 2026

Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Indeterminate GlobeNewswire
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
Aug. 12, 2026

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
Aug. 12, 2026

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Indeterminate GlobeNewswire
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
Aug. 12, 2026

SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination

Indeterminate GlobeNewswire
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Aug. 12, 2026

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission

Indeterminate GlobeNewswire
FACS Acquires Portland-Based G2 Consultants
Aug. 12, 2026

FACS Acquires Portland-Based G2 Consultants

Indeterminate GlobeNewswire
AI Integration Reshapes Protein Labeling Market, Driving Shift From Reagent Supply to Quantitative Data Workflows
Aug. 12, 2026

AI Integration Reshapes Protein Labeling Market, Driving Shift From Reagent Supply to Quantitative Data Workflows

Indeterminate GlobeNewswire
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Aug. 12, 2026

SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Middle East Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.